Carcinoma, Hepatocellular: all 3,251 studies
Page 14 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular CarcinomaCompletedNCT07845266Phase 1
- Effectiveness of Enhanced Web-Based Health Education on Self-Care Practices and Quality of Life Among Patients With Hepatocellular Carcinoma Undergoing TACEActive, not recruitingNCT07825519Not applicable
- Novel Abdominal Compression Positioning Technique for Respiratory Motion Management in Liver TumorsCompletedNCT07745153
- A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular CarcinomaActive, not recruitingNCT07713290Phase 1
- HCC-MPDS Multimodal Deep Learning Prognostic Model for Resectable HCCCompletedNCT07700082
- Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP ScoreCompletedNCT07687758
- Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in SohagActive, not recruitingNCT07669597
- Effects of EPA Supplementation on Patients With Unresectable Hepatocellular Carcinoma.CompletedNCT07664007Not applicable
- AI Multimodal Model for Liver Cancer Diagnosis and PrognosisActive, not recruitingNCT07658586
- Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVIActive, not recruitingNCT07658105Phase 2
- Contrast-Enhanced Ultrasound for Early Assessment of Microwave Ablation in HCCCompletedNCT07598331Not applicable
- Radiomics Subtyping to Guide Surgery vs. Maintenance Therapy After HCC DownstagingActive, not recruitingNCT07581769
- Standing Position Ultrasonography: Imaging Efficacy in Detecting Liver Diaphragmatic Dome Blind Area LesionsCompletedNCT07579533
- Patients With Primary Biliary CholangitisActive, not recruitingNCT07573514Not applicable
- Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular CarcinomaCompletedNCT07562763
- Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver CaActive, not recruitingNCT07493070Not applicable
- Individualized Surgical Guidance in HCC-BDTTCompletedNCT07483242
- HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary InvasionActive, not recruitingNCT07466225
- CECT Features of MVI Predict Response to TACE Plus TKI in Intermediate-stage HCCCompletedNCT07449065
- Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic Metastasis in Hepatocellular CarcinomaActive, not recruitingNCT07444905
- Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor MicroenvironmentActive, not recruitingNCT07437859
- Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver TransplantationCompletedNCT07418138
- SBRT for Liver Tumors, Liver Metastases, and Pancreatic TumorsCompletedNCT07407257Not applicable
- Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C PatientsCompletedNCT07404566
- Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver CancerCompletedNCT07386639
- Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative TrialActive, not recruitingNCT07380633Phase 2
- Using Machine Learning to Identify Responders to TACE or HAIC for uHCCCompletedNCT07368530
- Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular CarcinomaWithdrawnNCT07365839Phase 1
- Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled TrialCompletedNCT07349576Not applicable
- Enhanced Recovery After Surgery-Based Multimodal Preemptive Analgesia for Perioperative Management in Transarterial Chemoembolization of Intermediate-to-Advanced Hepatocellular CarcinomaCompletedNCT07315022Phase 4
- Use of Flow-Controlled Ventilation During CT-Guided Percutaneous Liver Tumor AblationCompletedNCT07291271
- A Prospective Observational Study on Efficacy of TARE for Early Stage HCCActive, not recruitingNCT07278102
- SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular CarcinomaSuspendedNCT07274774Phase 2
- The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective StudyCompletedNCT07272265Not applicable
- Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver CancerActive, not recruitingNCT07230080
- Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic ProcessesCompletedNCT07207304Not applicable
- Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver CirrhosisCompletedNCT07193316
- Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion ElectrodesCompletedNCT07192172Not applicable
- Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCCCompletedNCT07184424Not applicable
- Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery ChemoembolizationTerminatedNCT07178093Not applicable
- ThinkRadial: A Prospective Study of Transradial deTACE in HCC PatientsCompletedNCT07160374
- AI Multitask Model for HCC TreatmentCompletedNCT07157085
- Interventional AI-Human Collaboration for Liver Tumor DiagnosisCompletedNCT07153783Not applicable
- Dietary Intervention and Gut Microbiota in Hepatocellular Carcinoma (HCC)CompletedNCT07143955Not applicable
- A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular CarcinomaActive, not recruitingNCT07138885Phase 2
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular CarcinomaCompletedNCT07109336Not applicable
- Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular CarcinomaCompletedNCT07091942
- Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular CarcinomaActive, not recruitingNCT07081633Phase 2
- TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein InvasionCompletedNCT07075562Not applicable
- A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted TherapyActive, not recruitingNCT07065786
- TACE With Immune Agents for Angiogenesis in Hepatocellular CarcinomaCompletedNCT07053202Not applicable
- Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic LiverActive, not recruitingNCT07048665
- Precision Recurrence Risk Assessment in Early-stage Hepatocellular CarcinomaCompletedNCT07030842
- A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for RecurrenceActive, not recruitingNCT07009470Not applicable
- A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular CarcinomaWithdrawnNCT06994299Phase 2
- PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and SafetyCompletedNCT06991907Not applicable
- Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular CarcinomaSuspendedNCT06968195Phase 1
- Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular CarcinomaActive, not recruitingNCT06966986
- Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical ResectionActive, not recruitingNCT06934070
- EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)Active, not recruitingNCT06923761Phase 1/2
- SIRT or TACE Plus Lenvatinib and PD-(L)1 Inhibitor in High Burden HCCCompletedNCT06916546
- Stroke Volume Variation Versus Central Venous Pressure Guidance for Reducing Perioperative Blood Loss During Open Liver Resection, A Non-inferiority Randomized Controlled TrialCompletedNCT06905015Not applicable
- Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular CarcinomaWithdrawnNCT06902246Phase 2
- Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for ImmunotherapyCompletedNCT06899763
- HCC Innervation AssessmentActive, not recruitingNCT06886763
- Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without TACE for Advanced HCC With Vascular InvasionsCompletedNCT06881446
- Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor ThrombosisCompletedNCT06881433
- ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionCompletedNCT06856590Not applicable
- A Prospective Study of Cadonilimab in Hepatocellular Carcinoma After Radical Surgery With High Risk of RecurrenceTerminatedNCT06851104Phase 2
- Evaluate the Effect of Tirazamine on Primary Liver Cancer.TerminatedNCT06848556Phase 1/2
- Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical TrialActive, not recruitingNCT06842563
- Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver TransplantationCompletedNCT06799468
- Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
- Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular CarcinomaCompletedNCT06776185
- Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With ExplainabilityCompletedNCT06760494
- A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold StandardActive, not recruitingNCT06748755
- Ex-vivo Hypotermic Perfusion in Patients with Hepatocellular Carcinoma to Reduce the Incidence of Tumor RecurrenceCompletedNCT06720675
- Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and TremelimumabActive, not recruitingNCT06710223Phase 1
- Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma OrganoidActive, not recruitingNCT06699524
- Triple Recipient Strategy Using Split, Domino, and Auxiliary TechniquesCompletedNCT06683820
- Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular CarcinomaActive, not recruitingNCT06682377Not applicable
- A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular CarcinomaActive, not recruitingNCT06679985Phase 2
- Different Abbreviated MRI for Hepatocellular Carcinoma DiagnosisCompletedNCT06663904
- Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung CancerSuspendedNCT06653023Early Phase 1
- Artificially Intelligent Model for Accurate Detection of HCCCompletedNCT06637059
- naVIGation Invitations Liver surveillANce upTakeActive, not recruitingNCT06635694
- HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCCActive, not recruitingNCT06632106
- HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)CompletedNCT06631326
- A Cross Sectional Study Evaluating the Mean Levels of Alpha Fetoprotein in Patients of Hepatocellular Carcinoma and Its Correlates in PakistanCompletedNCT06629857
- A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.CompletedNCT06626724
- A Prototype AI Algorithm Versus Liver Imaging Reporting and Data System (LI-RADS) Criteria in Diagnosing HCC on CTCompletedNCT06626087Not applicable
- Calculator Predicts Early Mortality Post Hepatocellular Carcinoma ResectionCompletedNCT06621485
- Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in KoreaCompletedNCT06620510
- Streamlined Resin Y90 Radiation Segmentectomy for Small HCCActive, not recruitingNCT06618300
- "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular CarcinomaActive, not recruitingNCT06590844Phase 4
- A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)Active, not recruitingNCT06590246Phase 1/2
- Histotripsy (HistoSonics®) for Liver TumoursActive, not recruitingNCT06579833Not applicable
- Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC PatientsCompletedNCT06550739
- the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver CarcinomaCompletedNCT06549829Not applicable